| Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration Y Zhang, A Desai, SY Yang, KB Bae, MI Antczak, SP Fink, S Tiwari, ... Science 348 (6240), aaa2340, 2015 | 277 | 2015 |
| Neratinib, a novel HER2-targeted tyrosine kinase inhibitor SR Tiwari, P Mishra, J Abraham Clinical breast cancer 16 (5), 344-348, 2016 | 74 | 2016 |
| Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer SR Tiwari, P Mishra, P Raska, B Calhoun, J Abraham, H Moore, GT Budd, ... Breast cancer research and treatment 158, 189-193, 2016 | 28 | 2016 |
| Does scalp cooling have the same efficacy in black patients receiving chemotherapy for breast cancer? A Dilawari, C Gallagher, P Alintah, A Chitalia, S Tiwari, R Paxman, ... The Oncologist 26 (4), 292-e548, 2021 | 17 | 2021 |
| Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer F Lynce, MJ Blackburn, R Zhuo, C Gallagher, OM Hahn, M Abu‐Khalaf, ... Cancer 127 (19), 3622-3630, 2021 | 11 | 2021 |
| Efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab [TCH-P] in non-metastatic HER2+ breast cancer: The Cleveland Clinic experience. SR Tiwari, B Calhoun, J Abraham, GT Budd, HCF Moore, A Fanning, ... Journal of Clinical Oncology 33 (15_suppl), 531-531, 2015 | 6 | 2015 |
| Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or … F Lynce Age (mean (SD) 51, 11.54, 2022 | 5 | 2022 |
| Tissue regeneration. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348, aaa2340 Y Zhang, A Desai, SY Yang, KB Bae, MI Antczak, SP Fink, S Tiwari, ... | 5 | 2015 |
| Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005 SR Tiwari, T Sussman, K Kota, HC Moore, AJ Montero, GT Budd, ... Cancer Research 78 (4_Supplement), P5-21-26-P5-21-26, 2018 | 3 | 2018 |
| Abstract P2-10-10: Lower pathologic complete response rate with dual-HER2 blockage and chemotherapy in African Americans and ethnic minorities SR Tiwari, P Mishra, A Dilawari, CM Gallagher, A Chitalia, P Wehner, ... Cancer Research 80 (4_Supplement), P2-10-10-P2-10-10, 2020 | 1 | 2020 |
| Lower pathologic complete response rate with dual-HER2 blockage and chemotherapy in African Americans and ethnic minorities SR Tiwari, P Mishra, A Dilawari, CM Gallagher, A Chitalia, P Wehner, ... CANCER RESEARCH 80 (4), 2020 | 1 | 2020 |
| Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study F Lynce, C Mainor, RN Donahue, X Geng, G Jones, I Schlam, H Wang, ... Nature communications 15 (1), 2691, 2024 | | 2024 |
| Abstract P6-05-09: Cardiovascular Risk Evaluation for Breast Cancer Survivors: A Pilot Study I Schlam, D Debnath, C Gallagher, AA Dilawari, SR Tiwari, M Aschalew, ... Cancer Research 83 (5_Supplement), P6-05-09-P6-05-09, 2023 | | 2023 |
| Scalp cooling to prevent chemotherapy induced alopecia (CIA) in black patients: Differences in efficacy? AA Dilawari, P Alintah, R Paxman, A Chitalia, C Gallagher, SR Tiwari, ... Journal of Clinical Oncology 38 (15_suppl), 12101-12101, 2020 | | 2020 |
| Abstract P2-13-07: A lifestyle intervention program for obese breast cancer survivors using shared appointments, technology, and community partners in an underserved area I Schlam, P Alintah, C Gallagher, M Boisvert, A Chitalia, S Tiwari, ... Cancer Research 80 (4_Supplement), P2-13-07-P2-13-07, 2020 | | 2020 |
| Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study F Lynce, R Zhuo, M Blackburn, C Gallagher, O Hahn, M Abu-Khalaf, ... Cancer Research 80 (4_Supplement), P1-19-20-P1-19-20, 2020 | | 2020 |
| Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study F Lynce, R Zhuo, M Blackburn, C Gallagher, O Hahn, M Abu-Khalaf, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| A lifestyle intervention program for obese breast cancer survivors using shared appointments, technology, and community partners in an underserved area I Schlam, P Alintah, C Gallagher, M Boisvert, A Chitalia, S Tiwari, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Abstract P5-14-07: Impact of time to treatment (TTT) on recurrence free survival in non metastatic invasive breast cancer SR Tiwari, P Elson, K Tullio, GT Budd Cancer Research 77 (4_Supplement), P5-14-07-P5-14-07, 2017 | | 2017 |
| Improved outcomes in stage I HER2 positive breast cancer patients treated with trastuzumab and chemotherapy. SR Tiwari, P Raska, HCF Moore, H Emamekhoo, J Abraham, GT Budd, ... Journal of Clinical Oncology 34 (15_suppl), 594-594, 2016 | | 2016 |
